Equity Research, Broker Reports, and media content on CTI BIOPHARMA CORP

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about CTI BIOPHARMA CORP
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on CTI BIOPHARMA CORP. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
06Dec16 03:30 PRN PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical Activity In High-Risk Patients With Advanced Myelofibrosis In Late-Breaking Session At ASH Annual Meeting
01Dec16 09:01 PRN CTI BioPharma Presents Nonclinical Pharmacology Study Demonstrating Pacritinib Has Distinct Profile Amongst JAK Inhibitors At EORTC-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium
22Nov16 11:00 PRN Biotech Stocks on Investors' Radar -- Vertex Pharma, Nektar Therapeutics, CTI BioPharma, and Sage Therapeutics
21Nov16 09:01 PRN CTI BioPharma Announces Phase 3 Data from the PERSIST-2 Trial of Pacritinib to be Presented in Late-Breaking Session at ASH Annual Meeting
08Nov16 09:01 PRN CTI BioPharma Reports Third Quarter 2016 Financial Results
07Oct16 10:30 PRN Biotech Stocks Technical Reports -- Tesaro, CTI BioPharma, Sage Therapeutics, and Lexicon Pharma
03Oct16 06:30 PRN CTI BioPharma Announces Retirement Of President And CEO
  • Frequency of research reports


  • Research reports on


  • Providers covering